Here’s why I’d forget about the Fevertree Drinks share price ‘fad’

Fevertree Drinks (LON: FEVR) has had a poorer 2019 than it expected, but could 2020 be even worse?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

In my early investing days, I learned a lot from a Motley Fool colleague who had the knack of identifying what he called ‘fad’ stocks. They’re stocks that capture the mood of the moment, a passing fashion… but typically boom and then bust.

Perhaps they’re selling a new product that’s doing the rounds among young people. Or maybe a company is just making a big deal out of nothing special and advertising it big.

A what specialist?

Today, I’m examining Fevertree Drinks (LSE: FEVR), whose share price boomed in 2018. When I first saw Fevertree described as a tonic water specialist, my fad alert started sounding loudly in my head.

We’ve had all kinds of booze fads in recent years. Does anyone remember alcopops? Or beer with lemon stuck in the neck of the bottle? Or ready-made cocktails? Whenever I look at the supermarket booze section these days, I see more flavoured gins than just about anything else. But that’s a fad, and it will pass.

Now, Fevertree makes more than just fancy tonic waters, it does all sorts of mixers too. But tonic waters do seem to dominate. A quick check on the firm’s products reveals Elderflower tonic water, Aromatic tonic water, Clementine & Cinnamon tonic water… and many more.

I suspect there probably is a longer-term market for fancy mixer drinks, but not as big as hopeful growth investors think. It’s a market that’s very easy to get into too, and I don’t really see how Fevertree has any kind of protective moat or competitive advantage.

Competition

In my search for Fevertree products, I found ‘botanical brewery’ Fentimans offering Botanical, Pink Grapefruit, Mediterranean Orange, and even Connoisseur tonic waters. Then I found Double Dutch brand Cucumber and Watermelon tonic water.

The big names, like Coca-Cola and Schweppes are getting in on the act too — fancy some Russchian Aromatic Citrus tonic water? And then the big supermarkets, like Tesco, are offering their own brands.

I reckon the young people buying all this stuff in the bars probably won’t even know who makes their mixers. Just as long as they can be seen drinking their fashionable, I don’t know, South Seas Tulip tonic water or whatever, I can’t see them caring. People will just buy whatever the bar happens to stock. Until the ‘fancy mixers’ fad is over.

Shares?

So that’s my take on the products — probably decent enough, but probably set to go the way of all those previous drinking fads. But what about Fevertree Drinks shares?

The share price is way down from its peak, suffering an extra crunch when the firm’s latest year-end trading update was released. On 20 January, Fevertree shares lost more than a quarter of their value in just the one day. The update confirmed all my worst fears about rising competition.

Even after that dip, we’re still looking at a forward P/E of probably about 28 — around twice the FTSE 100‘s long-term average. I think Fevertree is still an overpriced fad stock.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has recommended Tesco. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Buffett at the BRK AGM
Investing Articles

Here’s why I like Tesco shares, but won’t be buying any!

Drawing inspiration from famed investor Warren Buffett's approach, our writer explains why Tesco shares aren't on his shopping list.

Read more »

Investing For Beginners

If the HSBC share price can clear these hurdles, it could fly in 2026

After a fantastic year, Jon Smith points out some of the potential road bumps for the HSBC share price, including…

Read more »

Investing Articles

I’m thrilled I bought Rolls-Royce shares in 2023. Will I buy more in 2026?

Rolls-Royce has become a superior company, with rising profits, buybacks, and shares now paying a dividend. So is the FTSE…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

With Warren Buffett about to step down, what can investors learn?

Legendary investor Warren Buffett is about to hand over the reins of Berkshire Hathaway after decades in charge. How might…

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

I asked ChatGPT for the perfect passive income ISA and it said…

Which 10 passive income stocks did the world's most popular artificial intelligence chatbot pick for a Stocks and Shares ISA?

Read more »

Tŵr Mawr lighthouse (meaning "great tower" in Welsh), on Ynys Llanddwyn on Anglesey, Wales, marks the western entrance to the Menai Strait.
Investing Articles

How I generated a 66.6% return in my SIPP in 2025 (and my strategy for 2026!)

By focusing on undervalued, high-potential stocks, this writer achieved market-beating SIPP returns in 2025 – here’s how he aims to…

Read more »

Happy young female stock-picker in a cafe
Investing Articles

New to the stock market? Here’s how you can give yourself a huge advantage

Stock market crashes can make buying shares intimidating. But investors don’t need  specialist skills or knowledge to give themselves a…

Read more »

Investing Articles

Could Nvidia shares make me a fortune in 2026, or lose me one?

Will Nvidia shares head further up in 2026, or are they set for a reversal if AI overvaluation fears ripple…

Read more »